14 Jul 2016
9m

Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies

Podcast cover

Journal of Clinical Oncology (JCO) Podcast

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies